IL17A and metabolic dysfunction-associated steatohepatitis: Our data showed that, while recombinant IL-23 is sufficient to drive IL-17A producing cell expansion and pro-inflammatory myeloid cell infiltration in liver, Il23r-/- mice are not protected from liver inflammation and fibrosis in two NASH models, suggesting the contribution of IL-23 signaling to NASH pathogenesis is minimal.